The usage of Phase Ib clinical trials for Alzheimer patients were announced by INmune Bio, Inc. (NASDAQ: INMB), a company specializing in immunology which utilizes the patients’ immune system to fend off disease. The purpose of the trail is to test the use and safety of a brand new anti-inflammatory drug which takes out the inflammation that us harmful to the body, known as soluble tumor necrosis factor (sTNF),which is implicated by the ....
Tags : Alzheimer patients, related trial, INmune Bio, Inc., Phase Ib clinical trials ,
comments (0)